Kevin Czerney - 07 Nov 2024 Form 3 Insider Report for DENTSPLY SIRONA Inc. (XRAY)

Role
VP, Chief Accounting Officer
Signature
s/ Dane Baumgardner, Attorney-In-Fact for Kevin Czerney
Issuer symbol
XRAY
Transactions as of
07 Nov 2024
Net transactions value
$0
Form type
3
Filing time
12 Nov 2024, 16:07:54 UTC
Next filing
12 Nov 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding XRAY Common Stock 5,845 07 Nov 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding XRAY Stock Option (Right to Buy) 07 Nov 2024 Common Stock 4,200 $30.60 Direct F1
holding XRAY Stock Option (Right to Buy) 07 Nov 2024 Common Stock 4,000 $38.74 Direct F2
holding XRAY Phantom Stock (Dentsply Supplemental Savings Plan) DSSP 07 Nov 2024 Common Stock 322 Direct F3
holding XRAY Phantom Stock (Supplemental Executive Retirement Plan) SERP 07 Nov 2024 Common Stock 377 Direct F4
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Stock options vest in annual one-third (1/3) increments over a three (3) year period ending November 16, 2025.
F2 Stock options vest in annual one-third (1/3) increments over a three (3) year period ending March 3, 2026.
F3 Each share of phantom stock is the economic equivalent of one share of common stock. The shares of phantom stock become payable in common stock upon the reporting person's termination of employment.
F4 The shares of phantom stock become payable in common stock upon the reporting persons termination of employment.

Remarks:

Exhibit 24 - Power of Attorney